<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03150550</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-321</org_study_id>
    <secondary_id>2016-A00048-43</secondary_id>
    <nct_id>NCT03150550</nct_id>
  </id_info>
  <brief_title>Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention</brief_title>
  <acronym>Mindfulness</acronym>
  <official_title>Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lundbeck SAS 37-45</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among behavioral cognitive psychotherapies, new &quot;Mindfulness&quot; interventions allow patient to&#xD;
      identify, pay attention and accept external (sensory stimuli) and internal (cognition and&#xD;
      emotions) phenomena. This &quot;to do with&quot; training has yielded promising results in stress&#xD;
      management, prevention of depressive relapse, management of craving and an increase in&#xD;
      self-efficacy. Few studies (none in France) have attempted to measure the efficacy of this&#xD;
      technique on alcohol relapse, in particular by comparing it with a usual management strategy&#xD;
      (conventional relapse prevention therapy).&#xD;
&#xD;
      The main objective of this study is to compare the efficacy on alcoholic relapse (measured in&#xD;
      the &quot;first glass&quot; consumed), from a Mindfulness therapeutic program to a conventional Relapse&#xD;
      Prevention program. Secondary objectives are to demonstrate the efficacy of this program on&#xD;
      craving, self-efficacy, and secondary endpoints of relapse (massive alcoholism, number of&#xD;
      alcoholisation days).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each patient will perform 12 psychotherapeutic sessions (Mindfulness or Relapse Prevention)&#xD;
      over a period of 6 weeks. Patients will be evaluated by a practitioner different from the&#xD;
      practitioner who makes the psychotherapeutic management.&#xD;
&#xD;
      Patients will be assessed at inclusion (Initial visit), after the 12 sessions of management&#xD;
      (M0), 1 month (M1), 2 month (M2), 3 month (M3), 4 month (M4), 5 month (M5), 6 month (M6),&#xD;
      after initial visit as follows&#xD;
&#xD;
      Initial Visit&#xD;
&#xD;
        -  Signature of an informed consent form.&#xD;
&#xD;
        -  Demographic characteristics (gender, age, family status, professional status, level of&#xD;
           education …)&#xD;
&#xD;
        -  Clinical data (patient status, ongoing pharmacological treatment, withdrawal, previous&#xD;
           CBT ...)&#xD;
&#xD;
        -  Criteria and severity of alcohol dependence (DSM 5)&#xD;
&#xD;
        -  Evaluation of depressive symptomatology and severity (HAM-D)&#xD;
&#xD;
        -  Level of pre-intervention alcohol consumption (AUDIT-C)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Craving before alcohol withdrawal (EVA craving)&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Drinking habits (QHPBA)&#xD;
&#xD;
      After the 12 sessions (M0)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Depressive symptomatology and severity (HAM-D)&#xD;
&#xD;
        -  Level of alcohol consumption in post-intervention (AUDIT-C)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Craving after alcohol withdrawal (EVA craving)&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Distribution of the 1st Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
      At 1 month (M1)&#xD;
&#xD;
        -  Return of the 1st Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Distribution of the 2nd Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
      At 2 month (M2)&#xD;
&#xD;
        -  Return of the 2nd Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Distribution of the 3th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
      At 3 month (M3)&#xD;
&#xD;
        -  Return of the 3th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Distribution of the 4th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
      At 4 month (M4)&#xD;
&#xD;
        -  Return of the 4th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Distribution of the 5th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
      At 5 month (M5)&#xD;
&#xD;
        -  Return of the 5th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
&#xD;
        -  Distribution of the 6th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
      At 6 month (M6)&#xD;
&#xD;
        -  Return of the 6th Daily Alcohol Logbook (TLFB)&#xD;
&#xD;
        -  Data on treatments in progress or change in treatment&#xD;
&#xD;
        -  Mindfulness Skills (KIMS)&#xD;
&#xD;
        -  &quot;Binge drinking&quot; consumption&#xD;
&#xD;
        -  Self-efficacy to remain abstinent (QAE-Alcohol)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 21, 2017</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Simple Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of alcoholic relapses</measure>
    <time_frame>6 month</time_frame>
    <description>Proportion of patients with an alcohol consumption of at least one glass of alcohol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol relapse time</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement : Number of days elapsed between the end of treatment and the first relapse compare between the two interventions (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delay in &quot;heavy drinking&quot; relapse</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement : Number of days elapsed between the end of treatment and the first heavy drinking (≥4 glasses of alcohol for women and ≥6 glasses of alcohol for men) compare between the two interventions (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of consumption</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement : Number of consumption days during 6 month compare between the two interventions (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily quantities consumed</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement : Number of standard glasses consumed per day during 6 month compare between the two interventions (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of mindfulness skills</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement : Score at the KIMS Scale (Kentucky Inventory of Mindfulness Skills) evaluated each month, compare before and after intervention (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of alcohol craving</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement: Assessed daily on a VAS craving (Visual analogue scale) in the daily observation book, compare before and after intervention (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of self-efficacy</measure>
    <time_frame>6 month</time_frame>
    <description>Measurement: Assessed daily on a VAS self-efficacy (Visual analogue scale) in the daily observation book, compare before and after intervention (classic or &quot;mindfulness&quot;)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <arm_group>
    <arm_group_label>Relapse Prevention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will perform 12 classic psychotherapeutic sessions over a period of 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness Practice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will perform 12 mindfulness psychotherapeutic sessions over a period of 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness practice</intervention_name>
    <description>Mindfulness interventions are behavioral cognitive psychotherapies which allow patient to identify, pay attention and accept external (sensory stimuli) and internal (cognition and emotions) phenomena.</description>
    <arm_group_label>Mindfulness Practice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Relapse prevention</intervention_name>
    <description>It's a conventional relapse prevention program which allow to measure the alcoholic relapse in the first glass consumed.</description>
    <arm_group_label>Relapse Prevention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female aged 18 to 75 (including landmarks)&#xD;
&#xD;
          -  Patients in withdrawal for alcohol dependence according to DSM IV criteria (1994);&#xD;
             hospital or outpatient withdrawal of more than 10 days and less than 10 weeks.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Psychiatric comorbidity (dipsomaniac alcoholism, anteriority of one or more hypomanic&#xD;
             or manic episodes, psychoses, severe depression, severe suicidal risk)&#xD;
&#xD;
          -  Other addiction syndrome than tobacco and alcohol&#xD;
&#xD;
          -  Problems that impede participation in a group, such as severe borderline personality&#xD;
             disorder; antisocial personality; tendency to dissociation; phobias of interceptive&#xD;
             type (panic attacks and hypochondria ...)&#xD;
&#xD;
          -  Problems preventing the completion of questionnaires, such as cognitive dysfunctions,&#xD;
             dysfunctions of attention and concentration skills, or a language barrier&#xD;
&#xD;
          -  Severe recurring pathology&#xD;
&#xD;
          -  Need for individual weekly follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie GENESTE</last_name>
    <phone>04 73 75 47 84</phone>
    <email>j_geneste@chu-clermontferrand.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>France</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <contact_backup>
      <last_name>Julie GENESTE</last_name>
      <phone>04 73 75 47 84</phone>
      <email>j_geneste@chu-clermontferrand.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mindfulness</keyword>
  <keyword>Alcohol</keyword>
  <keyword>Alcohol Use Disorder</keyword>
  <keyword>Relapse</keyword>
  <keyword>Relapse Prevention</keyword>
  <keyword>Cognitive-behavioral therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

